🏆 PhosPrint SA was honored with the 2026 Start-up Entrepreneurship Award from the Athens Chamber of Commerce and Industry (ACCI)! This distinction is of particular significance to all of us. The award was accepted by the company’s CEO and President, Dr. Ioanna Zergioti, who thanked the Athens Chamber of Commerce and Industry for this outstanding recognition and highlighted something that fills us with pride: PhosPrint SA’s innovative in vivo laser bioprinting platform was

We successfully presented our innovation at LSI USA, joining a distinguished community of global leaders and innovators shaping the future of healthcare. Our CEO, Ioanna Zergioti, delivered a compelling presentation, showcasing our transformative technology and vision. We were delighted to connect with investors, strategic partners, and fellow pioneers, and we look forward to building on these valuable interactions. READ MORE

March 20, 2026 PhosPrint successfully completed its technical visits within the NEOLIVER project, achieving the first official installation of its GEN1 laser bioprinter outside the company.The system is now fully operational at DWI – Leibniz Institute for Interactive Materials in Aachen, supporting advanced bioprinting research and collaboration.This milestone strengthens the joint effort toward developing the world’s first autologous bioprinted liver and enhances the reprodu